arrow
M

Marco Valenti

department of biotechnological and applied clinical sciences
H指数:40
被引数:5,843

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Effectiveness and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 52-Week Retrospective Italian Study Focusing on Head and Neck Involvement

真实世界中利rikizumab在成人和青少年中重度特应性皮炎患者中的有效性与安全性:一项为期52周的意大利回顾性研究,重点关注头颈部受累情况

2026-03-280
OAAI
Long-Term Outcomes of Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: A Multicentre Cohort Study

中重度 Hidradenitis suppurativa 患者 Secukinumab 的长期疗效:一项多中心队列研究

2026-03-170
PRE
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry
2024-05-150
PRE